PD-L1 is an adverse prognostic factor for other cancers, such as non-small cell lung cancer, pancreatic undifferentiated carcinoma, thyroid, and prostate cancer [62,63,64] and also for squamous cell carcinoma of the tongue and the floor of the mouth [64]. Here, CD274 is linked to cancer.